Exagen Inc expected to post a loss of 47  cents a share - Earnings Preview

Exagen

08/05/2021 01:48

* Exagen Inc  XGN.OQ   XGN.O  is expected to show a rise in
quarterly revenue when it reports results on May 11 .
* The Vista, California-based company is expected to report   a
9.1% increase in revenue to $10.453 million from $9.58 million a
year ago, according to the mean estimate from 6 analysts, based
on Refinitiv data. 
​* Refinitiv's mean analyst estimate for Exagen Inc is for a
loss of 47 cents per share. For the same quarter last year, the
company reported a loss of 44 cents per share.
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 6 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts had risen by about 5.1%
in the last three months. ​
* Wall Street's median 12-month price target for Exagen Inc is
$25​, about 38.7% above​ its last closing price of $15.33. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Dec. 31 2020  -0.38       -0.41      -0.27     Beat    33.4
 Sep. 30 2020  -0.47       -0.47      -0.34     Beat    28.4
 Jun. 30 2020  -0.75       -0.76      -0.27     Beat    64.4​
 Mar. 31 2020  -0.48       -0.49      -0.44     Beat    10.2
 Dec.          -0.33​      -0.37      -0.27     Beat    26.4​
 31​ 2019​                                              
 Sep. 30 2019  -2.40       -2.40      -2.30     Beat    4.1​
 This summary was machine generated May 8 at 00:48 GMT.  All
figures in US dollars unless otherwise stated